Immunity Pharma Ltd.
PrivateTotal Funding Raised
$600,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Immunity Pharma Ltd. is a biotechnology company that develops peptide-based therapeutic drug candidates for the treatment of neurodegenerative diseases, with an initial focus on amyotrophic lateral sclerosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immunity Pharma Ltd. Comparables
Compare Immunity Pharma Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuvivo | 78% | |
| QurAlis | 78% | |
| Spinogenix, Inc. | 76% | |
Immunity Pharma Ltd. Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 155% MoM, reaching 1.5K.
- May 14, 2026
Monthly visitors increased 93% MoM.
Immunity Pharma Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Immunity Pharma Ltd.'s valuation, stock price, and market status.